News

The state plans to invest $6.5 million in funds from the 2021 American Rescue Plan Act toward a partnership with nonprofit RIP Medical Debt, which buys bundled medical debt portfolios from providers.

The Delinking Revenue from Unfair Gouging (DRUG) Act would require pharmacy benefit managers that contract with a carrier offering federal health benefits plans to "de-link" the fees they charge insurers from the price of drugs.  

Only about 3 in 10 believe the quality of care and services they receive reflect their costs.

As part of the negotiated settlement, the defendants paid more than $8.3 million in restitution.

The Biden administration took the first step in its Medicare drug price negotiation program for 10 of the costliest prescription drugs, giving drugmakers until March 2 to either accept the government's offer or make a counteroffer.

The Federal Trade Commission launched its inquiry of the 6 largest PBMs in June 2022, after Sen. Chuck Grassley (R-Iowa) had pressed the commission for years to review their role in determining prices for prescriptions like insulin.